Parker, William A E <br/><br/>
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study.  [electronic resource] 

 -  Platelets  2019 
 - 579-588 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1369-1635 
<br/><br/><label>Standard No.: </label>10.1080/09537104.2018.1478404  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--diagnosis<br/>Biomarkers<br/>Blood Platelets--drug effects<br/>Cause of Death<br/>Clopidogrel--therapeutic use<br/>Equilibrative Nucleoside Transporter 1--genetics<br/>Genetic Association Studies<br/>Genetic Predisposition to Disease<br/>Humans<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Polymorphism, Genetic<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>Proportional Hazards Models<br/>Purinergic P2Y Receptor Antagonists--therapeutic use<br/>Ticlopidine--therapeutic use<br/>Treatment Outcome